Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HLX01 vs Rituximab in RA
NCT03355872Phase 2Completed
- Sponsor
- Henlius
- Start
- Feb 2016
- Primary completion
- Aug 2018
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of rituximab in rheumatoid arthritis (RA), sponsored by Henlius. Started Feb 2016; status: completed.
02
Drugs
rituximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT03355872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03355872.